Fluicell AB (FLUI) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.017x

Based on the latest financial reports, Fluicell AB (FLUI) has a cash flow conversion efficiency ratio of 0.017x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr248.00K ≈ $26.69K USD) by net assets (Skr14.21 Million ≈ $1.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Fluicell AB stock valuation for the company's overall valuation and market capitalisation.

Fluicell AB - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Fluicell AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Fluicell AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fluicell AB ranked by their cash flow conversion efficiency. Explore FLUI cash flow quality score to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Nicoccino Holding AB
ST:NICO
-0.936x
NedSense Enterprises NV
AS:NEDSE
0.067x
C&C Group plc
LSE:CCR
0.072x
Austin Metals Ltd
AU:AYT
-0.023x
Nandani Creation Limited
NSE:JAIPURKURT
-0.166x
Belmont Resources Inc
V:BEA
-0.038x
CCH Holdings Ltd Ordinary Shares
NASDAQ:CCHH
N/A
Ambica Agarbathies & Aroma industries Limited
NSE:AMBICAAGAR
0.071x

Annual Cash Flow Conversion Efficiency for Fluicell AB (2016–2025)

The table below shows the annual cash flow conversion efficiency of Fluicell AB from 2016 to 2025. View FLUI live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr10.90 Million
≈ $1.17 Million
Skr-4.95 Million
≈ $-532.16K
-0.454x +44.32%
2024-12-31 Skr19.23 Million
≈ $2.07 Million
Skr-15.67 Million
≈ $-1.69 Million
-0.815x +98.73%
2023-12-31 Skr425.00K
≈ $45.74K
Skr-27.23 Million
≈ $-2.93 Million
-64.064x -7037.92%
2022-12-31 Skr23.45 Million
≈ $2.52 Million
Skr-21.04 Million
≈ $-2.26 Million
-0.898x +7.98%
2021-12-31 Skr19.11 Million
≈ $2.06 Million
Skr-18.64 Million
≈ $-2.01 Million
-0.975x -8.24%
2020-12-31 Skr19.50 Million
≈ $2.10 Million
Skr-17.57 Million
≈ $-1.89 Million
-0.901x +46.02%
2019-12-31 Skr10.22 Million
≈ $1.10 Million
Skr-17.07 Million
≈ $-1.84 Million
-1.669x -213.09%
2018-12-31 Skr23.37 Million
≈ $2.52 Million
Skr-12.46 Million
≈ $-1.34 Million
-0.533x +34.76%
2017-12-31 Skr9.58 Million
≈ $1.03 Million
Skr-7.83 Million
≈ $-842.74K
-0.817x +72.63%
2016-12-31 Skr1.84 Million
≈ $198.12K
Skr-5.50 Million
≈ $-591.56K
-2.986x --

About Fluicell AB

ST:FLUI Sweden Biotechnology
Market Cap
$4.64 Million
Skr43.13 Million SEK
Market Cap Rank
#28824 Global
#648 in Sweden
Share Price
Skr31.40
Change (1 day)
-0.32%
52-Week Range
Skr7.95 - Skr57.20
All Time High
Skr188.78
About

Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high precision cell biology that uses open volume microfluidics; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve sys… Read more